98. Eosinophilic gastrointestinal disease Clinical trials / Disease details

Clinical trials : 171 / Drugs : 184 - (DrugBank : 47) / Drug target genes : 42 - Drug target pathways : 141

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00728481 (ClinicalTrials.gov)	May 2008	15/7/2008	The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis	The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis	Eosinophilic Esophagitis;Gastroesophageal Reflux Disease;EE;GERD	Drug: Esomeprazole;Drug: Budesonide	Mayo Clinic	AstraZeneca	Completed	18 Years	80 Years	All	51	Phase 2/Phase 3	United States
2	NCT00895817 (ClinicalTrials.gov)	April 2008	6/5/2009	Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis	Comparison of Aerosolized Swallowed Fluticasone to Esomeprazole for the Treatment of Eosinophilic Esophagitis	Eosinophilic Esophagitis	Drug: Swallowed fluticasone;Drug: Esomeprazole	Walter Reed Army Medical Center	NULL	Completed	18 Years	N/A	All	42	N/A	United States
3	NCT00123656 (ClinicalTrials.gov)	August 2004	21/7/2005	Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis	Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis	Esophagitis	Drug: esomeprazole;Drug: fluticasone	University of Utah	American Society for Gastrointestinal Endoscopy	Completed	18 Years	80 Years	Both	30	Phase 2	United States